| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/22/2010 | US20100184644 Mucosal repair by tff dimer peptides |
| 07/22/2010 | US20100184643 Methods and Compounds Regulating the Erythroid Response to Iron Deficiency |
| 07/22/2010 | US20100184642 Transgenic Plants Expressing Cobalamin Binding Proteins |
| 07/22/2010 | US20100184641 Novel Plasma Protein Affinity Tags |
| 07/22/2010 | US20100184640 Dog diabetes |
| 07/22/2010 | US20100184639 Nucleic acids and polypeptides specific of the neisseria genus pathogenic strains |
| 07/22/2010 | US20100184638 Galanin Receptors and Brain Injury |
| 07/22/2010 | US20100184637 Pharmaceutical and/or cosmetic composition containing an active antioxydant principle and cell energy activator |
| 07/22/2010 | US20100184636 Method of Regulating Mammalian Target-of-Rapamycin Activity by Interaction Between Phospholipase D and Raptor |
| 07/22/2010 | US20100184215 Modified thioredoxin |
| 07/22/2010 | US20100183749 Topically active steroids for use in radiation and chemotherapeutics injury |
| 07/22/2010 | US20100183723 Fetal Skin Cell Protein Compositions for the Treatment of Skin Conditions, Disorders or Diseases and Methods of Making and Using the Same |
| 07/22/2010 | US20100183719 Surgical Applications for BMP Binding Protein |
| 07/22/2010 | US20100183718 Compositions and treatment of heart deficiency in non-human animals |
| 07/22/2010 | US20100183714 Gastroresistant pharmaceutical dosage form comprising n-(2-(2- phthalimidoethoxy)-acetyl)-l-alanyl-d-glutamic acid (lk-423) |
| 07/22/2010 | US20100183706 Peptide epitopes of apolipoprotein b |
| 07/22/2010 | US20100183700 Implantable pump for protein delivery for obesity control by drug infusion into the brain |
| 07/22/2010 | US20100183699 Compositions and methods to cross link polymer fibers |
| 07/22/2010 | US20100183695 Cerberus/coco derivatives and uses thereof |
| 07/22/2010 | US20100183685 Tumor and infectious disease therapeutic compositions |
| 07/22/2010 | US20100183682 Method of treating allergies using tgf-beta1 and allergens |
| 07/22/2010 | US20100183666 Methods of reducing papillomavirus infection using immunomodulatory polynucleotide sequences |
| 07/22/2010 | US20100183658 Novel Compounds for Enhancing MHC Class II Therapies |
| 07/22/2010 | US20100183657 Fusion proteins of mycobacterium tuberculosis |
| 07/22/2010 | US20100183654 Immunoreactive protein orthologs of ehrlichia canis and e. chaffeensis |
| 07/22/2010 | US20100183646 Mage-a3/hpv 16 peptide vaccines for head and neck cancer |
| 07/22/2010 | US20100183645 Active or passive immunization against proapoptotic neurotrophins for the treatment and/or prevention of neurodegenerative diseases |
| 07/22/2010 | US20100183643 Cancer vaccines containing epitopes of oncofetal antigen |
| 07/22/2010 | US20100183642 Novel multimeric cd40 ligands, method for preparing same and use thereof for preparing drugs |
| 07/22/2010 | US20100183640 Methods and compositions for the treatment of fibrotic conditions and impaired lung function and to enhance lymphocyte production |
| 07/22/2010 | US20100183634 Multifunctional nucleic acid nano-structures |
| 07/22/2010 | US20100183629 Antagonists of endothelial differentiation gene subfamily 3 (edg-3, s1p3) receptors for prevention and treatment of ocular disorders |
| 07/22/2010 | US20100183626 Human phospholipase a2 epsilon |
| 07/22/2010 | US20100183625 Treatment of Mucositis with Kallikrein Inhibitors |
| 07/22/2010 | US20100183624 Methods for increasing adiponectin |
| 07/22/2010 | US20100183622 Vpr function and activity |
| 07/22/2010 | US20100183620 Compositions and methods for regulating collagen and smooth muscle actin expression by serpine2 |
| 07/22/2010 | US20100183617 Compositions and methods for regulating sas1r |
| 07/22/2010 | US20100183613 Methods of using mevalonate decarboxylase (mvd) antagonists |
| 07/22/2010 | US20100183612 Methods of treatment using ctla4 mutant molecules |
| 07/22/2010 | US20100183610 Genetic polymorphisms associated with alzheimer's disease, methods of detection and uses thereof |
| 07/22/2010 | US20100183609 Taci-immunoglobulin fusion proteins |
| 07/22/2010 | US20100183607 Risk markers for cardiovascular disease |
| 07/22/2010 | US20100183600 RAF Inhibitors and Their Uses |
| 07/22/2010 | US20100183599 Methods of treating multiple myeloma and myeloma-induced bone resorption using integrin antagonists |
| 07/22/2010 | US20100183598 Methods of treating cardiovascular disorders |
| 07/22/2010 | US20100183597 Drak2 expression is associated with diabetes |
| 07/22/2010 | US20100183594 Steroid-sparing methods of treating brain edema |
| 07/22/2010 | US20100183592 Human epo receptor agonists, compositions, methods and uses for preventing or treating glucose intolerance related conditions |
| 07/22/2010 | US20100183589 Human blood proteins expressed in monocot seeds |
| 07/22/2010 | US20100183588 Mutated Netrin-4, Fragments Thereof And Their Use As Medicines |
| 07/22/2010 | US20100183587 Therapeutic Compositions for Treatment of Corneal Disorders |
| 07/22/2010 | US20100183584 Conformation and activity of gbeta5 complexes |
| 07/22/2010 | US20100183582 Hemostatic compositions containing sterile thrombin |
| 07/22/2010 | US20100183581 Compositions and Methods for Modulating Blood-Brain Barrier Transport |
| 07/22/2010 | US20100183580 Treatment of pigs for reducing the feed conversion ratio or increasing the growth rate |
| 07/22/2010 | US20100183579 Memory enhancing protein |
| 07/22/2010 | US20100183578 Nitroprotein biomarkers for copd |
| 07/22/2010 | US20100183577 Enzyme replacement therapy for treating lysosomal storage diseases |
| 07/22/2010 | US20100183573 membrane polypeptide for use in designing therapeutic for proliferative, inflammatory, skin, arthritic, cardiovascular and autoimmune disorders; cancer, immunological-related, blood-related and skin-related disorders |
| 07/22/2010 | US20100183569 Porous composite material, preparation process thereof and use to realize tissue engineering devices |
| 07/22/2010 | US20100183567 Novel Mammalian Multipotent Stem Cells and Compositions, Methods of Preparation and Methods of Administration Thereof |
| 07/22/2010 | US20100183562 Sub -population of hematopoietic stem cells that express the crisp-1 protein |
| 07/22/2010 | US20100183560 Angiogenesis-modulating compositions and uses |
| 07/22/2010 | US20100183555 Methods and kits for determining drug sensitivity in patients infected with hcv |
| 07/22/2010 | US20100183554 Anti-CD3 Antibodies and Methods of Use Thereof |
| 07/22/2010 | US20100183553 Composition and Methods for Affecting Metallocorrinoid Uptake |
| 07/22/2010 | US20100183552 1-[2-amino-3-(substituted alkyl)-3h-benzimidazolylmethyl]-3-substituted-1,3-dihydro-benzoimidazol-2-ones and structural analogs |
| 07/22/2010 | US20100183551 Macrocyclic Compounds As Antiviral Agents |
| 07/22/2010 | US20100183550 Benzothienopyridines For Use As Inhibitors Of EG5 Kinesin |
| 07/22/2010 | US20100183549 Bacterial vaccines with cell wall-associated ceramide-like glycolipids and uses thereof |
| 07/22/2010 | US20100183548 Tweak receptor |
| 07/22/2010 | US20100183547 Unmarked Recombinant Intracellular Pathogen Immunogenic Compositions Expressing High Levels of Recombinant Proteins |
| 07/22/2010 | US20100183546 Method for Increasing CD8+ Cytotoxic T Cell Responses and for Treating Multiple Sclerosis |
| 07/22/2010 | US20100183545 Targeted cargo protein combination therapy |
| 07/22/2010 | US20100183544 Method of treatment |
| 07/22/2010 | US20100183543 Method for the treatment of radiation-induced neutropenia by administration of a multi-pegylated granulocyte colony stimulating factor (g-csf) variant |
| 07/22/2010 | US20100183542 Synergism Between Activated Immune Cells and Conventional Cancer Therapies |
| 07/22/2010 | US20100183541 Methods of Treating Autoimmune Diseases |
| 07/22/2010 | US20100183519 Topical Poloxamer Formulations for Enhancing Microvascular Flow: Compositions and Uses Thereof |
| 07/22/2010 | US20100183516 Self coupling recombinant antibody fusion proteins |
| 07/22/2010 | US20100183515 Compositions and methods for treating the vertebral column |
| 07/22/2010 | US20100183510 EphB RECEPTOR-BINDING PEPTIDES |
| 07/22/2010 | US20100183502 Stabilized Uncoated Particles of Reversed Liquid Crystalline Phase Materials |
| 07/22/2010 | US20100183501 Medical Devices With Nanotextured Titanium Coating |
| 07/22/2010 | CA2749862A1 A recombinant alpha-hemolysin polypeptide of staphylococcus aureus, having a deletion in the stem domain and heterologous sequences inserted |
| 07/22/2010 | CA2749824A1 Identification of novel antagonist toxins of t-type calcium channel for analgesic purposes |
| 07/22/2010 | CA2749802A1 New stable formulations of recombinant human albumin-human granulocyte colony stimulating factor fusion protein |
| 07/22/2010 | CA2749786A1 New stable formulations of recombinant human albumin-human granulocyte colony stimulating factor |
| 07/22/2010 | CA2749772A1 Mutated antithrombins, a process for preparing the same and their use as drugs |
| 07/22/2010 | CA2749690A1 Compositions for the treatment of gluten intolerance and uses thereof |
| 07/22/2010 | CA2749544A1 Methods for increasing adiponectin |
| 07/22/2010 | CA2749401A1 Low-concentration nutritional composition |
| 07/22/2010 | CA2749319A1 Melanocortin analogs with antimicrobial activity |
| 07/22/2010 | CA2749278A1 Deoxyactagardine derivatives |
| 07/22/2010 | CA2748860A1 Hylauronic acid containing compositions for treatment of wounds, scars, post-surgical adhesion formation |
| 07/22/2010 | CA2748662A1 Protein conjugate having an endopeptidase-cleavable bioprotective moiety |
| 07/22/2010 | CA2744088A1 Peptidomimetic macrocycles |
| 07/21/2010 | EP2209006A1 Use of the Desmoglein I protein for screening soluble anti-ageing active ingredients |
| 07/21/2010 | EP2208793A1 Protein providing inducible resistance to glycopeptides, in particular in gram-positive bacteria |